Molecular Pharmacology (USA) Ltd MLPH:OTCPK

*Data is delayed | Exchange | USD
Last | 04/16/24 EDT
0.0006UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0006
  • 52 Week High0.00
  • 52 Week High Date04/08/24
  • 52 Week Low0.00
  • 52 Week Low Date01/10/24

Key Stats

  • Market Cap599,732.28
  • Shares Out999.55M
  • 10 Day Average Volume14,900
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0006
  • 52 Week High0.00
  • 52 Week High Date04/08/24
  • 52 Week Low0.00
  • 52 Week Low Date01/10/24
  • Market Cap599,732.28
  • Shares Out999.55M
  • 10 Day Average Volume14,900
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-105,049.998
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Molecular Pharmacology (USA) Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Molecular Pharmacology (USA) Limited (Molecular USA) is an Australia-based development Stage company together with its subsidiary, Molecular Pharmacology Pty. Ltd. (MPLA) is in the business of developing and commercializing an analgesic and anti-inflammatory molecule known as Tripeptofen. The Company’s over-the-counter anti-pain and anti-inflammatory products sold for the treatment of acute localized pain are based on non-steroidal anti-inflammatory drugs (NSAIDs). The...
Jeffery Edwards
President, Chief Executive Officer, Chief Financial Officer, Director
Address
Drug Discovery Research Ctr
284 Oxford St
Leederville, WAS
6007
Australia